Status:
COMPLETED
Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial
Lead Sponsor:
Universidade de Passo Fundo
Conditions:
Dyspepsia
Eligibility:
FEMALE
Phase:
PHASE1
PHASE2
Brief Summary
Background: Gastric glitch is a new functional disease characterized by severe and transient epigastric pain occurring after challenges such as drinking alcohol and eating specific foods. Aims: In thi...
Detailed Description
Objective: To evaluate the effect of prucalopride and buspirone, compared to placebo, in the prevention of gastric pain crises, in a double-blind clinical trial of a single patient. Methods: Female, 3...
Eligibility Criteria
Inclusion
- adult patient suffering from severe gastric pain after ingestion of a small amount of wine
Exclusion
- N/A (N-of-1 trial)
Key Trial Info
Start Date :
January 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 6 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT05377619
Start Date
January 6 2022
End Date
March 6 2022
Last Update
May 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Passo Fundo
Passo Fundo, Rio Grande do Sul, Brazil, 99010-080